Hosted on MSN2d
Lantheus’s (NASDAQ:LNTH) Q4 Sales Top Estimates, Stock SoarsRadiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q4 CY2024 results , with sales up 10.5% year on year to ...
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session after the company ...
Leerink Partners analyst Danielle Antalffy maintained a Buy rating on Lantheus (NASDAQ:LNTH) on Thursday, setting a price target of $34, which is approximately 17.57% above the ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Lantheus (LNTH – Research Report) and Argenx Se ...
Lantheus Holdings Inc (LNTH) reports robust sales growth for PYLARIFY and DEFINITY, while navigating increased operating ...
Welcome to the Lantheus Fourth Quarter and Full Year 2024 Conference Call. [Operator Instructions]. This call is being recorded and a replay will be available in the Investors section of the company's ...
Lantheus (NASDAQ:LNTH – Get Free Report) is anticipated to release its earnings data before the market opens on Thursday, ...
In trading on Wednesday, shares of Lantheus Holdings Inc (Symbol: LNTH) crossed above their 200 day moving average of $94.93, changing hands as high as $95.94 per share. Lantheus Holdings Inc ...
LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) reported 2024 financial and operational results on February 26 th , producing sales of over $1 billion for Pylarify during ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback